DrugPatentWatch Database Preview
Graviti Pharms Company Profile
What is the competitive landscape for GRAVITI PHARMS, and what generic and branded alternatives to GRAVITI PHARMS drugs are available?
GRAVITI PHARMS has four approved drugs.
Summary for Graviti Pharms
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Graviti Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Graviti Pharms | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 209912-003 | Jun 18, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Graviti Pharms | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 209912-001 | Jun 18, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Graviti Pharms | FENOFIBRATE | fenofibrate | TABLET;ORAL | 210606-002 | Aug 17, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Graviti Pharms | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 207570-001 | Sep 30, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Graviti Pharms | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 209912-002 | Jun 18, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
